Delivery Order SPE2DB20D1047-SPE2DB25FF64E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $1,654.99. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,990.49 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units. The contract utilizes firm fixed price terms and carries an ultimate completion date of April 25, 2025. This award represents a child delivery order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $3,111.86. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is September 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $2,190.50. This firm fixed-price delivery order, which is not set-aside designated, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2025. The contract represents a continuation of AmerisourceBergen's ongoing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Clobazam 10 mg tablets (100-count units) under a firm fixed price contract valued at $5,615.84. This non-set-aside delivery order represents a single fulfillment against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. The contract is to be completed by...
- The Defense Logistics Agency awarded a $1,555.93 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.42 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) on August 11, 2025, with a completion date of August 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. The delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $1,555.93. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by May 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.34 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery falls...
- The Defense Logistics Agency awarded a delivery order valued at $4,667.79 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF64EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $3,401.17 and an ultimate completion date of June 2, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains through the DLA Medical Supply Chain. This delivery order for Clobazam, a neurological treatment medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for the Defense Health Agency and other federal healthcare systems through the comprehensive global pharmaceutical support vehicle provided by the prime IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/30/25 |